Sort   by:  
 Page size 
GenomicsSF3B1 mutant-induced missplicing of MAP3K7 causes anemia in myelodysplastic syndromes
SF3B1 mutant-induced missplicing of MAP3K7 causes anemia in myelodysplastic syndromes
PRJNA777473 | ENA
GenomicsRNA-Seq of 22RV1 human prostate cancer cells with knockdown of MAP3K7 and CHD1
RNA-Seq of 22RV1 human prostate cancer cells with knockdown of MAP3K7 and CHD1
PRJNA713360 | ENA
GenomicsRNA-Seq of LAPC4 human prostate cancer cells with knockdown of MAP3K7 and CHD1
RNA-Seq of LAPC4 human prostate cancer cells with knockdown of MAP3K7 and CHD1
PRJNA713351 | ENA
UnknownCoordinate loss of MAP3K7 and CHD1 promotes aggressive prostate cancer.
Not available
S-EPMC4531265 | biostudies-literature
GenomicsRNA-Seq of LNCaP human prostate cancer cells with knockdown of MAP3K7 and/or CHD1
RNA-Seq of LNCaP human prostate cancer cells with knockdown of MAP3K7 and/or CHD1
PRJNA713349 | ENA
TranscriptomicsRNA-Seq of LAPC4 human prostate cancer cells with knockdown of MAP3K7 and CHD1
Purpose: The goal of this study is to identify transcriptome-wide changes that occur in a human prostate cell line with knockdown of MAP3K7(TAK1) and CHD1, in the presence and absence of androgens. We utilize this cell line as a model of an aggressive prostate cancer subtype consisting of deletions ...
ORGANISM(S): Homo sapiens 
2021-04-12 | GSE168665 | GEO
TranscriptomicsRNA-Seq of 22RV1 human prostate cancer cells with knockdown of MAP3K7 and CHD1
Purpose: The goal of this study is to identify transcriptome-wide changes that occur in a human prostate cell line with knockdown of MAP3K7(TAK1) and CHD1, in the presence and absence of androgens. We utilize this cell line as a model of an aggressive prostate cancer subtype consisting of deletions ...
ORGANISM(S): Homo sapiens 
2021-04-12 | GSE168670 | GEO
UnknownThe MAP3K7 gene: Further delineation of clinical characteristics and genotype/phenotype correlations.
Not available
S-EPMC9544731 | biostudies-literature
TranscriptomicsRNA-Seq of LNCaP human prostate cancer cells with knockdown of MAP3K7 and/or CHD1
Purpose: The goal of this study is to identify transcriptome-wide changes that occur in a human prostate cell line with knockdown of MAP3K7(TAK1) and CHD1, in the presence and absence of androgens. We utilize this cell line as a model of an aggressive prostate cancer subtype consisting of deletions ...
ORGANISM(S): Homo sapiens 
2021-04-12 | GSE168663 | GEO
UnknownThe MAP3K7-mTOR Axis Promotes the Proliferation and Malignancy of Hepatocellular Carcinoma Cells.
Not available
S-EPMC6558008 | biostudies-literature
Sort   by:  
 Page size